The CDC is offering this grant to enhance Mozambique’s capacity for high-quality laboratory services and systems under the President’s Emergency Plan for AIDS Relief (PEPFAR). This grant aims to build upon significant progress in HIV diagnosis and management, particularly increasing viral load and early infant diagnosis testing coverage. Its purpose is to help Mozambique achieve UNAIDS 95-95-95 goals by expanding HIV, TB, and opportunistic infection testing, improving laboratory governance, and developing technical and managerial capabilities. The initiative will implement robust data and quality management systems, including continuous quality improvement programs, to support multi-disease testing and respond effectively to public health threats, ensuring sustainable and integrated laboratory services.
Opportunity ID: 350506
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Dec 04, 2023 |
Last Updated Date: | Jan 05, 2024 |
Original Closing Date for Applications: | Feb 12, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Feb 21, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 22, 2024 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
This modification is to update the application due date to reflect 2/21/2024. | Jan 05, 2024 | |
NA | Dec 04, 2023 | |
NA | Dec 04, 2023 | |
Dec 04, 2023 | ||
Oct 06, 2023 |
DISPLAYING: Synopsis 4
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Dec 04, 2023 |
Last Updated Date: | Jan 05, 2024 |
Original Closing Date for Applications: | Feb 12, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Feb 21, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 22, 2024 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Dec 04, 2023 |
Last Updated Date: | Dec 05, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 12, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Dec 04, 2023 |
Last Updated Date: | Dec 04, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 12, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 04, 2023 |
Last Updated Date: | Dec 04, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Feb 12, 2024 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
pepfarfoas@cdc.gov Email:pepfarfoas@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH-24-0096 |
Funding Opportunity Title: | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Oct 06, 2023 |
Last Updated Date: | Oct 06, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Feb 24, 2025 |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $7,000,000 for Year 1, subject to the availability of funds.High-quality laboratory systems and services are essential for accurate diagnosis, treatment, and management of HIV and opportunistic infections (OI) amongst people living with HIV (PLHIV). Mozambique has made tremendous progress toward building technical capacity and optimizing the laboratory network to provide timely access to early infant diagnosis (EID) and viral load (VL) testing services for all eligible clients. VL coverage has rapidly increased from 67% in 2018, to 83% in 2022, contributing to improved patient monitoring and outcomes for PLHIV. This NOFO plans to build upon current accomplishments and support government institutions in Mozambique to strengthen and sustain laboratory systems and services towards achieving the UNAIDS 95-95-95 goals.The NOFO aims to attain comprehensive coverage for both VL and EID testing, facilitate the expansion of HIV testing for enhanced case detection, strengthen the diagnosis of TB and other OI, enhance the governance of laboratory systems, build technical, scientific, and managerial capabilities, and implement robust laboratory data and quality management systems (QMS). This approach encompasses comprehensive quality assurance (QA) and continuous quality improvement (QI) programs essential for HIV rapid test site certification and laboratory accreditation. This NOFO seeks to strengthen integration of laboratory systems and services to support multi-disease testing and improve responsiveness to emerging public health threats. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:pepfarfoas@cdc.gov |
Related Documents
Folder 350506 Full Announcement-Full Announcement -> Foa_Content_of_CDC-RFA-GH-24-0096.pdf
Folder 350506 Revised Full Announcement-Revised Full Announcement -> Revised Foa_Content_of_CDC-RFA-GH-24-0096.pdf
Packages
Agency Contact Information: | Emily Dale pepfarfoas@cdc.gov Email: pepfarfoas@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.067 | CDC-RFA-GH-24-0096 | Strengthening Mozambique’s Capacity to Integrate and Sustain High-Quality Laboratory Services and Systems under the President’s Emergency Plan for AIDS Relief (PEPFAR) | PKG00284040 | Jan 05, 2024 | Feb 21, 2024 | View |
Package 1
Mandatory forms
350506 SF424_4_0-4.0.pdf
350506 Project_AbstractSummary_2_0-2.0.pdf
350506 SFLLL_2_0-2.0.pdf
350506 SF424A-1.0.pdf
350506 BudgetNarrativeAttachments_1_2-1.2.pdf
350506 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
350506 OtherNarrativeAttachments_1_2-1.2.pdf